MARAGANORE JOHN
SEC CIK 1180432 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TAK | TAKEDA PHARMACEUTICAL CO LTD | Dir | 10.4K | — | — | 1 | 2026-07-01 | 2026-07-01 |
| COAG | Hemab Therapeutics Holdings, Inc. | Dir | 35.9K | — | — | 1 | 2026-05-04 | 2026-05-04 |
| AGIO | AGIOS PHARMACEUTICALS, INC. | Dir | 30.0K | — | — | 1 | 2022-05-20 | 2022-05-20 |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | CEO, Dir | 228.0K | — | $12.62M | 7 | 2021-08-13 | 2021-12-22 |
Most active insiders at TAK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Plump Andrew Stewart | Pres, R, D, Dir | — | $5.34M |
| 2 | Kim Julie So-Young | Pres, CEO, Dir | — | $1.52M |
| 3 | Duprey Lauren Rusckowski | Chief Transformation Off | — | $1.45M |
| 4 | Greenway Nicola Deidre Petal | CHRO | — | $956.7K |
| 5 | Bitetti Teresa Marie | Pres, OBU | — | $855.2K |
| 6 | Platford Giles Richard | Pres, IBU | — | $531.5K |
| 7 | Furney Natalie Anne Marie | Gbl GC | — | $527.8K |
| 8 | Ricci Gabriele | Chief Data, Tech. Off | — | $429.0K |
| 9 | Shannon Elaine Mary | Pres, Gbl Supply, Quality | — | $425.4K |
| 10 | Pignagnoli Agosti Marcello | Head, Strat, Port. Dev | — | $392.6K |
| 25 | MARAGANORE JOHN | Dir | — | — |
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-06 18:28 | 2026-07-01 | TAK | TAKEDA PHARMACEUTICAL CO LTD | MARAGANORE JOHN | Dir | A - Grant | $0.00 | +3,800 | 10.4K | +58% | $0 |
| DM | 2026-05-04 16:20 | 2026-05-04 | COAG | Hemab Therapeutics Holdings, Inc. | MARAGANORE JOHN | Dir | C - Cnv Deriv | — | +35.9K | 35.9K | New | — |
| D | 2022-05-24 | 2022-05-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | MARAGANORE JOHN | Dir | M - OptEx | $0.00 | +1,585 | 30.0K | +6% | $0 |
| M | 2021-12-23 | 2021-12-22 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | MARAGANORE JOHN | CEO, Dir | F - Tax | $188.98 | -6,636 | 228.0K | -3% | -$1.25M |
| 2021-12-23 | 2021-12-21 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | MARAGANORE JOHN | CEO, Dir | A - Grant | $0.00 | +14.2K | 234.3K | +6% | $0 | |
| DM | 2021-12-14 | 2021-12-10 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | MARAGANORE JOHN | CEO, Dir | M - OptEx | $74.50 | +5,367 | 220.1K | +2% | +$399.8K |
| DM | 2021-11-12 | 2021-11-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | MARAGANORE JOHN | CEO, Dir | S - Sale+OE | $171.52 | -34.0K | 214.8K | -14% | -$5.83M |
| D | 2021-11-12 | 2021-11-12 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | MARAGANORE JOHN | CEO, Dir | M - OptEx | $7.10 | +34.0K | 248.7K | +16% | +$241.2K |
| DM | 2021-08-16 | 2021-08-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | MARAGANORE JOHN | CEO, Dir | S - Sale+OE | $199.78 | -34.0K | 218.8K | -13% | -$6.79M |
| D | 2021-08-16 | 2021-08-13 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | MARAGANORE JOHN | CEO, Dir | M - OptEx | $7.10 | +34.0K | 248.7K | +16% | +$241.3K |
Purchase Sale Sale after option exercise All abbreviations